Diabetic Foot Infections

A diabetic foot infection (DFI) is a soft-tissue or bone infection arising in a foot wound in a person with diabetes, almost always on a background of peripheral neuropathy (loss of protective sensation) and frequently complicated by peripheral arterial disease (PAD) that both delays healing and limits antibiotic delivery to the tissue. DFI sits at the intersection of medicine and surgery: infection severity — assessed with the IWGDF/IDSA classification — determines whether a patient is treated as an outpatient with oral antibiotics or hospitalized for IV therapy and urgent debridement, and antibiotics alone are frequently insufficient without surgical drainage or debridement of infected and necrotic tissue.^[1]

Because neuropathy blunts pain, a severe or even bone-involving infection can present with deceptively little discomfort, so clinicians must rely on visible signs of inflammation and a low threshold for probing and imaging rather than on how much pain the patient reports.

A diabetic foot ulcer — the entry point for infection. Neuropathy often means the wound is far more advanced than the patient's pain level suggests. (Mark A. Dreyer, DPM, FACFAS, CC BY 4.0, Wikimedia Commons)

Diabetic foot infection presents on a spectrum from simple superficial cellulitis around an ulcer to a deep, limb- or life-threatening infection involving muscle, tendon, joint, or bone. A wound is infected — not simply present — when at least 2 classic signs of inflammation are found, or purulent discharge is present.^[1]

• Local swelling or induration around the wound.
• Erythema extending beyond the wound margin — in lighter skin this is typically visible redness, while in darker skin tones inflammation may appear purple, brown, grey, or dusky, or may be more reliably detected by warmth, edema, and tenderness than by colour change alone.
• Local tenderness or pain — but a patient with significant loss of protective sensation may report little or no pain despite a severe underlying infection, so the absence of pain never excludes serious infection.
• Local warmth.
• Purulent (pus-like) discharge.
• Malodour, increased or new drainage, or a wound that stops healing or begins breaking down after a period of stability.
• In advanced infection: bullae, skin necrosis, crepitus (suggesting gas-forming organisms), or a diffusely swollen, erythematous ("sausage") toe or digit, which should raise concern for underlying osteomyelitis or septic arthritis.

• Peripheral neuropathy with loss of protective sensation (unable to perceive a 10-gram Semmes-Weinstein monofilament).
• Peripheral arterial disease.
• Previous foot ulcer, previous foot infection, or previous amputation.
• Foot deformity (bunions, hammertoes, prior Charcot arthropathy) that creates abnormal pressure points.
• Long-standing diabetes and long-term suboptimal glycemic control.
• Diabetic nephropathy, including dialysis dependence.
• Diabetic retinopathy or visual impairment limiting the ability to self-inspect the feet.
• Limited joint mobility, or reduced mobility/ability to reach the feet for self-care.
• Poorly fitting footwear, walking barefoot, or a foreign body/pressure source inside the shoe.
• Trauma, recent foot surgery, or a recent change in footwear or activity level.
• Callus formation, nail pathology (onychomycosis, ingrown toenail), or maceration between the toes.
• Smoking.
• Immunosuppression.
• Living alone, cognitive impairment, or otherwise limited access to regular foot care.

Differential diagnosis of a foot problem in a person with diabetes

Many noninfectious foot conditions mimic an infected diabetic foot wound, and several genuinely infectious syndromes need different management from one another — work through this differential before committing to a diagnosis and antibiotic course.

Erythema may vary in intensity and tone with skin pigmentation, dermatologic conditions, vascular disease, and infection severity — do not rely on colour change alone, particularly in darker skin tones, and weight warmth, edema, and tenderness more heavily when erythema is hard to see.

History

• Duration of diabetes and long-term glycemic control.
• Diabetes complications: retinopathy, nephropathy, neuropathy, vasculopathy.
• Previous foot ulcer, infection, Charcot arthropathy, gangrene, trauma, amputation, or foot surgery.
• Smoking status.
• Known or suspected trauma (blunt or penetrating).
• Fever, chills, or rigors.
• New or different pain, or new swelling, in the limb — remembering that neuropathy can blunt these symptoms even with severe infection.
• Recent change in footwear.
• Recent antimicrobial therapy.
• Recent worsening of glycemic control, which can itself be an early sign of infection.
• Presence and duration of any skin ulcer, and any recent change such as new or increased drainage or odour.

Physical examination

• Skin discoloration and lymphangitis; remember erythema appearance varies with skin pigmentation and vascular status.
• Increased warmth or coldness; dependent rubor.
• Swelling and joint stiffness.
• Malodour.
• Corns and calluses.
• The ulcer, skin crack, or traumatic wound itself — location, size, depth, vascularity, and drainage — and probe the base with a sterile blunt instrument for palpable or exposed bone.
• Nail problems (ingrown toenail, onychomycosis) and the web spaces between the toes (cracks, maceration, ulceration, drainage).
• Deformity of the toes, foot, or ankle.
• Pedal pulses, capillary refill, and evidence of arterial obstruction.
• Neuropathy, assessed with inability to perceive a 10-gram Semmes-Weinstein monofilament.
• Footwear inspection — rough edges/seams, fit, a foreign body or object penetrating the sole, blood staining, odour, pressure marks, and wear pattern.

Peripheral arterial disease: assess in every patient

Check pedal pulses, capillary refill, and skin temperature/colour in every patient with a diabetic foot infection — infection and peripheral arterial disease (PAD) frequently coexist, and their combination markedly worsens both healing and amputation risk.^[2]

Obtain an ankle-brachial index (ABI) and, where available, toe pressures or Doppler arterial waveforms. An ABI ≤0.8 suggests delayed wound-healing potential; an ABI ≤0.5, or a toe pressure ≤40 mmHg, suggests inadequate arterial inflow and a very poor chance of healing without revascularization — refer urgently for vascular assessment at this threshold.

Do not defer vascular assessment until after the infection is treated: in a patient with infection plus critical limb ischemia, obtain an urgent combined surgical and vascular consultation to determine the need and timing for drainage/debridement together with revascularization — treating the infection alone will not heal an ischemic wound.

Recognizing and confirming osteomyelitis

Suspect osteomyelitis in any ulcer that is large, deep, chronic, overlying a bony prominence, or associated with a diffusely swollen ("sausage") toe or digit.

Probe the ulcer base with a sterile blunt metal instrument: if bone is palpated at the base of a diabetic foot or ankle ulcer, treat osteomyelitis as present until proven otherwise. A positive probe-to-bone test in a patient with a deep or high-risk ulcer supports the diagnosis; a negative test does not reliably exclude it, particularly when overall clinical suspicion is high.^[3]

Obtain plain radiographs of the foot and ankle as the initial imaging study — early osteomyelitis may not yet show radiographic change, so a normal initial film does not exclude it; repeat radiographs in 2 to 3 weeks if suspicion remains high. Add ESR and CRP as supporting laboratory evidence.

Order MRI when the diagnosis remains uncertain after clinical assessment, probe-to-bone testing, plain radiographs, and inflammatory markers — MRI is the preferred advanced imaging study; bone scintigraphy, leukocyte scintigraphy, or PET are reasonable alternatives when MRI is unavailable or contraindicated.^[1]

Whenever feasible, confirm osteomyelitis with a bone (not soft-tissue) culture, obtained either intraoperatively or by percutaneous biopsy, before committing a patient to a prolonged antibiotic course.

Wound culture: technique matters

Do not rely on a superficial swab of the ulcer surface or drainage to guide antibiotic therapy — a swab predominantly recovers surface contaminants and colonizing organisms rather than the true pathogens driving the infection deeper in the wound, and its results correlate poorly with deep tissue or bone culture.^[1]

Obtain a culture only from clinically infected wounds, not from uninfected ulcers, preferably as a tissue specimen collected by curettage or biopsy after cleansing and debriding the wound — this correlates far better with the organisms actually driving the infection and is the preferred specimen whenever the necessary skill/equipment is available.

Send tissue for conventional culture and susceptibility testing as the first-line microbiology method rather than molecular/PCR-based testing for routine identification of the causative organism(s).

Laboratory studies

• CBC with differential.
• Blood cultures if systemic involvement is suspected.
• ESR and CRP to help diagnose osteomyelitis and to follow response to treatment.
• Fasting blood glucose — worsening glycemic control can be an early sign of sepsis.
• Electrolytes and renal and hepatic function, both as a baseline and to guide safe antimicrobial dosing.

• Cure the acute infection and prevent its recurrence.
• Preserve the limb — avoid amputation whenever the infection and vascular status allow it.
• Fully heal the underlying wound, not just resolve the infection.
• Identify and definitively treat osteomyelitis when present, rather than treating it as ordinary soft-tissue infection.
• Restore functional weight-bearing and ambulation with appropriate footwear/orthoses once healed.
• Optimize glycemic control as part of the treatment, not as a separate afterthought.

• Surgical drainage and debridement of infected/necrotic tissue and abscesses — send purulent material and débrided tissue for culture at the time of surgery.
• Offloading the wound (pressure relief) with a removable walker boot, total contact cast, custom orthosis, or crutches — essential for healing any weight-bearing ulcer, infected or not.^[4]
• Regular sharp debridement of callus and nonviable tissue at the wound edge, which reduces bacterial load and abnormal pressure.
• Moist wound-healing dressings (for example, saline-moistened gauze or a hydroactive gel); switch to an absorptive dressing (carboxymethylcellulose or alginate) if the wound is excessively moist, or to a débriding dressing if necrotic debris is present at the base — no specific dressing type or antimicrobial-impregnated dressing has been shown to be superior.
• Do not use foot baths or soaking — this macerates the skin and is specifically associated with Pseudomonas aeruginosa infection.
• Continue wound-healing measures until the wound is fully healed, even after infection has cleared.
• Urgent vascular assessment and consideration of revascularization in any patient whose peripheral arterial disease is limiting healing potential — an ischemic wound will not heal on antibiotics and dressings alone.
• Optimize glycemic control — poor control impairs both infection clearance and wound healing.
• Smoking cessation.
• Do not use topical antiseptics, silver-based dressings, honey, bacteriophage therapy, negative-pressure wound therapy, hyperbaric or topical oxygen therapy, or adjunctive granulocyte colony-stimulating factor for the specific purpose of treating the infection — none has shown benefit for this indication.^[1]
• Do not use topical or locally applied antibiotics (sponges, creams, or antibiotic-loaded cement) in combination with systemic antibiotics for either soft-tissue infection or osteomyelitis.

Pregnancy

Diabetic foot infection in pregnancy is uncommon but occurs, most often in pre-existing (pregestational) type 1 or type 2 diabetes with established neuropathy or vasculopathy rather than gestational diabetes. Favour beta-lactams (cephalexin, amoxicillin/clavulanate, cefazolin, ceftriaxone) and clindamycin, which are considered compatible with pregnancy. Avoid fluoroquinolones (ciprofloxacin, levofloxacin, moxifloxacin) and tetracyclines (doxycycline) throughout pregnancy given effects on developing cartilage and bone/teeth. Avoid sulfamethoxazole/trimethoprim near term given a theoretical risk of neonatal hyperbilirubinemia. Manage jointly with obstetrics, infectious diseases, and the foot-care team.

Breastfeeding

Most beta-lactams, clindamycin, and vancomycin are considered compatible with breastfeeding. Avoid doxycycline and fluoroquinolones when a suitable alternative exists. Metronidazole is compatible with breastfeeding at standard multidose regimens.

Pediatric

Diabetic foot infection, as described in this chapter, is not a recognized pediatric disease process — it results from decades of accumulated neuropathy and vasculopathy that essentially never occur in childhood, even in longstanding type 1 diabetes. A child or adolescent with diabetes who develops a foot wound and infection should be assessed and treated under pediatric infectious disease and endocrinology direction, with weight-based dosing from a pediatric reference, rather than by this adult-oriented chapter.

Older adults

Older adults carry the highest burden of diabetic foot infection given the cumulative duration of neuropathy, vasculopathy, and prior foot complications. Review renal function before dosing any renally cleared agent, review for polypharmacy and interactions — several agents in this chapter interact with warfarin, including the cephalosporins, fluoroquinolones, sulfamethoxazole/trimethoprim, metronidazole, and doxycycline — and confirm functional and social supports for offloading adherence and wound care.

Renal impairment

Dose-adjust piperacillin/tazobactam, the carbapenems (ertapenem, imipenem/cilastatin, meropenem), cefazolin, cefuroxime, ceftazidime, ciprofloxacin, levofloxacin, sulfamethoxazole/trimethoprim, and vancomycin for reduced renal function; consult a renal dosing reference or pharmacist for the specific adjustment. Daptomycin and linezolid do not require renal dose adjustment, though daptomycin's dosing interval may still need review in severe renal impairment. Vancomycin requires level monitoring regardless of baseline renal function.

Hepatic impairment

Most agents in this chapter do not require specific hepatic dose adjustment; use caution and monitor liver enzymes with prolonged courses of any hepatically metabolized agent, and review dosing individually with a pharmacist in significant hepatic impairment.

Peripheral arterial disease

See Assessment & Diagnosis for the ankle-brachial index/toe pressure thresholds that trigger urgent vascular referral.^[2] In a patient with significant PAD, extend the soft-tissue infection treatment duration toward 3 to 4 weeks even for infections that would otherwise qualify for a shorter course, and do not delay vascular consultation while treating the infection — revascularization, when needed, is part of achieving cure, not an optional adjunct.

Reassess clinically within 48 to 72 hours for a hospitalized or severe infection, and within about a week for a stable outpatient mild-to-moderate infection — look for decreasing erythema, edema, warmth, and drainage as the primary markers of response.

Trend ESR and CRP in osteomyelitis to help judge response to therapy alongside clinical and radiographic findings, and repeat plain radiographs to follow osteomyelitis over the treatment course.

Monitor renal function throughout therapy with any renally cleared or nephrotoxic agent, obtain vancomycin levels (trough or AUC per institutional protocol), monitor creatine kinase at least weekly with daptomycin, and monitor a complete blood count at least weekly if linezolid is continued beyond 2 weeks.

Reinforce offloading adherence, footwear, and glycemic control at every visit — these change the trajectory of healing as much as the antibiotic choice.

Confirm osteomyelitis remission only after a minimum of 6 months without relapse following completion of antibiotic therapy — a shorter symptom-free interval is not sufficient to call it cured.^[1]

Schedule ongoing preventive foot care and screening (see Risk Factors) even after the current infection resolves, since recurrence risk remains high.

1. Confirm the antibiotic regimen was actually taken correctly, at the correct dose, and that gastrointestinal absorption is not impaired.
2. Re-examine for an undrained abscess, retained foreign body, or necrotic tissue requiring debridement — antibiotics cannot resolve infection around a collection or dead tissue that has not been removed.
3. Reassess specifically for osteomyelitis if it has not already been diagnosed or excluded.
4. Reassess vascular status — undiagnosed or undertreated peripheral arterial disease is a common, correctable cause of apparent antibiotic failure.
5. Obtain, or repeat, a deep tissue or bone culture, ideally after debridement, to guide culture-directed therapy rather than continuing broad empiric coverage indefinitely.
6. Consider a resistant or unusual organism, particularly if the patient had recent antibiotic exposure or a prolonged hospital stay.
7. Refer to infectious diseases and a foot/vascular surgical team if infection persists despite confirmed adherence, adequate debridement, and culture-directed therapy.

• Prescribing systemic or topical antibiotics for a clinically uninfected foot ulcer.
• Relying on a superficial wound swab, rather than a deep tissue or bone specimen, to select antibiotic therapy.
• Treating with antibiotics alone when necrotic tissue, an abscess, or deep infection is present — surgical debridement is part of the treatment, not an optional adjunct.
• Missing osteomyelitis by not probing to bone, not ordering imaging, or dismissing a chronic non-healing ulcer over a bony prominence.
• Failing to assess peripheral arterial disease, or treating infection without addressing a coexisting revascularization need.
• Using the same short treatment duration for osteomyelitis as for soft-tissue-only infection.
• Adding empiric MRSA or Pseudomonas coverage routinely, without a specific risk factor, when narrower therapy would work — this drives resistance without added benefit.
• Recommending foot baths or soaking, which macerates skin and predisposes to Pseudomonas infection.
• Overlooking warfarin and other interactions with several of these antibiotics — the cephalosporins, fluoroquinolones, sulfamethoxazole/trimethoprim, metronidazole, and doxycycline can all raise INR.
• Continuing IV therapy longer than necessary instead of stepping down to an appropriate oral agent once the patient is clinically stable.
• Misdiagnosing early Charcot arthropathy as cellulitis or infection in a warm, swollen foot with no wound and no systemic signs — check whether erythema decreases with elevation, a clue that favours Charcot arthropathy over infection.

How to use this table: Doses are adult doses and require patient-specific confirmation (renal/hepatic function, weight, allergy history). Pediatric dosing is weight-based per the current product monograph unless stated. Drug pricing is intentionally omitted. Select any drug name to open its complete Pharmasist Drug Database page.

Carbapenems

Cephalosporins, first-generation

A patient with a prior IgE-mediated penicillin reaction (angioedema, immediate urticaria, anaphylaxis) should not receive a cephalosporin given potential cross-reactivity; a prior measles-like rash allows cephalosporin use with caution.

Cephalosporins, second-generation

Cephalosporins, third-generation

Fluoroquinolones

Glycopeptides

Lincosamides

Lipopeptides

Nitroimidazoles

Oxazolidinones

Penicillins

Sulfonamide combinations

Tetracyclines

Evidence note: Drug inventory, dosing, adverse effects, and comments reflect standard Canadian practice, cross-checked against the current IWGDF/IDSA guideline.^[1]